Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Repositioning Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Repositioning Overall Market Size
2.1 Global Drug Repositioning Market Size: 2022 VS 2029
2.2 Global Drug Repositioning Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in Global Market
3.2 Top Global Drug Repositioning Companies Ranked by Revenue
3.3 Global Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in Global Market
3.6.1 List of Global Tier 1 Drug Repositioning Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Repositioning Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drug Repositioning Market Size Markets, 2022 & 2029
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - Global Drug Repositioning Revenue & Forecasts
4.2.1 By Type - Global Drug Repositioning Revenue, 2018-2023
4.2.2 By Type - Global Drug Repositioning Revenue, 2024-2029
4.2.3 By Type - Global Drug Repositioning Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Repositioning Market Size, 2022 & 2029
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Others
5.2 By Application - Global Drug Repositioning Revenue & Forecasts
5.2.1 By Application - Global Drug Repositioning Revenue, 2018-2023
5.2.2 By Application - Global Drug Repositioning Revenue, 2024-2029
5.2.3 By Application - Global Drug Repositioning Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drug Repositioning Market Size, 2022 & 2029
6.2 By Region - Global Drug Repositioning Revenue & Forecasts
6.2.1 By Region - Global Drug Repositioning Revenue, 2018-2023
6.2.2 By Region - Global Drug Repositioning Revenue, 2024-2029
6.2.3 By Region - Global Drug Repositioning Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drug Repositioning Revenue, 2018-2029
6.3.2 US Drug Repositioning Market Size, 2018-2029
6.3.3 Canada Drug Repositioning Market Size, 2018-2029
6.3.4 Mexico Drug Repositioning Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drug Repositioning Revenue, 2018-2029
6.4.2 Germany Drug Repositioning Market Size, 2018-2029
6.4.3 France Drug Repositioning Market Size, 2018-2029
6.4.4 U.K. Drug Repositioning Market Size, 2018-2029
6.4.5 Italy Drug Repositioning Market Size, 2018-2029
6.4.6 Russia Drug Repositioning Market Size, 2018-2029
6.4.7 Nordic Countries Drug Repositioning Market Size, 2018-2029
6.4.8 Benelux Drug Repositioning Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drug Repositioning Revenue, 2018-2029
6.5.2 China Drug Repositioning Market Size, 2018-2029
6.5.3 Japan Drug Repositioning Market Size, 2018-2029
6.5.4 South Korea Drug Repositioning Market Size, 2018-2029
6.5.5 Southeast Asia Drug Repositioning Market Size, 2018-2029
6.5.6 India Drug Repositioning Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drug Repositioning Revenue, 2018-2029
6.6.2 Brazil Drug Repositioning Market Size, 2018-2029
6.6.3 Argentina Drug Repositioning Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Repositioning Revenue, 2018-2029
6.7.2 Turkey Drug Repositioning Market Size, 2018-2029
6.7.3 Israel Drug Repositioning Market Size, 2018-2029
6.7.4 Saudi Arabia Drug Repositioning Market Size, 2018-2029
6.7.5 UAE Drug Repositioning Market Size, 2018-2029
7 Drug Repositioning Companies Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Drug Repositioning Major Product Offerings
7.1.4 Teva Drug Repositioning Revenue in Global Market (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Drug Repositioning Major Product Offerings
7.2.4 Novartis Drug Repositioning Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Drug Repositioning Major Product Offerings
7.3.4 Mylan Drug Repositioning Revenue in Global Market (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Major Product Offerings
7.4.4 Johnson & Johnson Drug Repositioning Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Drug Repositioning Major Product Offerings
7.5.4 Pfizer Drug Repositioning Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Bausch Health
7.6.1 Bausch Health Company Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Drug Repositioning Major Product Offerings
7.6.4 Bausch Health Drug Repositioning Revenue in Global Market (2018-2023)
7.6.5 Bausch Health Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Drug Repositioning Major Product Offerings
7.7.4 GSK Drug Repositioning Revenue in Global Market (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 ChemRar Group
7.8.1 ChemRar Group Company Summary
7.8.2 ChemRar Group Business Overview
7.8.3 ChemRar Group Drug Repositioning Major Product Offerings
7.8.4 ChemRar Group Drug Repositioning Revenue in Global Market (2018-2023)
7.8.5 ChemRar Group Key News & Latest Developments
7.9 Glenmark
7.9.1 Glenmark Company Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Drug Repositioning Major Product Offerings
7.9.4 Glenmark Drug Repositioning Revenue in Global Market (2018-2023)
7.9.5 Glenmark Key News & Latest Developments
7.10 Fujifilm
7.10.1 Fujifilm Company Summary
7.10.2 Fujifilm Business Overview
7.10.3 Fujifilm Drug Repositioning Major Product Offerings
7.10.4 Fujifilm Drug Repositioning Revenue in Global Market (2018-2023)
7.10.5 Fujifilm Key News & Latest Developments
7.11 Dr. Reddy
7.11.1 Dr. Reddy Company Summary
7.11.2 Dr. Reddy Business Overview
7.11.3 Dr. Reddy Drug Repositioning Major Product Offerings
7.11.4 Dr. Reddy Drug Repositioning Revenue in Global Market (2018-2023)
7.11.5 Dr. Reddy Key News & Latest Developments
7.12 R-Pharma
7.12.1 R-Pharma Company Summary
7.12.2 R-Pharma Business Overview
7.12.3 R-Pharma Drug Repositioning Major Product Offerings
7.12.4 R-Pharma Drug Repositioning Revenue in Global Market (2018-2023)
7.12.5 R-Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer